Financing - August 3, 2017
Bonesupport project receives Vinnova grant
Swedish BONESUPPORT has announced that one of the components of its pipeline projects focused on developing a new CERAMENT product capable of enhancing bone growth has been awarded SEK 8 million in external funding from Sweden’s innovation agency Vinnova. The project titled Developing Functionalized Biomaterials with Bone Active Molecules as Novel Strategies/Tools for Secondary Prevention and […]
Biotech Business - June 29, 2017
Cytovation announces private fundraising round of NOK 20m
The financing was led by a group of private investors in Norway and the company will use these funds to advance lead product CyPep-1 into a Phase I clinical trial. Cytovation is developing CyPep-1, a peptide consisting of 27 amino acids that selectively targets cutaneous warts through the destruction of the cell membrane and creating […]
Biotech Business - June 27, 2017
BerGenBio awarded NOK 24m from Innovasjon Norge
BerGenBio announces the award of a NOK 24 million (USD 2.85m) grant from Innovasjon Norge to support the clinical development of BGB324 in combination with Merck & Co.’s KEYTRUDA (pembrolizumab) in patients with advanced lung cancer. BerGenBio will sponsor a Phase II study multi-centre study of BGB324 in combination with KEYTRUDA in patients with previously […]
Biotech Business - June 16, 2017
Creating a more mature European biotech ecosystem
What can researchers, investors, and funding agencies do to unlock biotech’s potential? The European life science industry has great potential to improve patient care, solve public health challenges, and drive economic growth. Europe is a leader in life science research, but is behind the United States, in particular, in translating discoveries into medical therapies and […]
Financing - June 7, 2017
NeuroVive receives research grant
The company receives close to 1 million SEK in a research grant from Swedish innovation agency, Vinnova, for developing a new treatment for genetic mitochondrial diseases. NeuroVive receives the grant from Vinnova’s 2017 Swelife call to continue progressing the preclinical project NVP015. The cutting edge NVP015 project is aimed at developing a new pharmacological treatment […]
Financing - May 9, 2017
BC Platforms closes a USD $10 million financing round
The round was led by Debiopharm Innovation Fund in conjunction with Tesi, a Finnish venture capital and private equity company, and was supported by BC Platforms’ existing investors. To date, the company has established partnerships with over 50 enterprise level healthcare units and biobanks globally in 19 countries representing more than 2 million subjects. “We are […]
